UK medical-device company developing a hyperthermic intravesical chemotherapy platform for bladder cancer.
| Date | Round | Amount |
|---|---|---|
| Mar 2026 | Series A UK's Combat Medical raised a GBP 2.6M Series A first close led by the T&J Meyer Family Foundation to fund its phase 3 bladder-cancer trial. | $3.3M |